Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
30885 | 131 | 37.5 | 91% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1336 | 7916 | MARINER//SLEEPING BEAUTY//TRANSGENIC CHICKEN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | 2A PEPTIDE | Author keyword | 11 | 54% | 11% | 14 |
2 | FMDV 2A | Author keyword | 6 | 100% | 3% | 4 |
3 | 2A | Author keyword | 4 | 40% | 6% | 8 |
4 | CO TRANSLATION | Author keyword | 2 | 67% | 2% | 2 |
5 | ECTO NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1 | Author keyword | 2 | 67% | 2% | 2 |
6 | MULTICISTRONIC | Author keyword | 1 | 50% | 2% | 2 |
7 | TRICISTRONIC | Author keyword | 1 | 50% | 2% | 2 |
8 | BICISTRONIC VECTOR | Author keyword | 1 | 19% | 4% | 5 |
9 | PRECLIN ONCOL IMMUNOL | Address | 1 | 33% | 2% | 2 |
10 | 2A SELF PROCESSING SEQUENCE | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 2A PEPTIDE | 11 | 54% | 11% | 14 | Search 2A+PEPTIDE | Search 2A+PEPTIDE |
2 | FMDV 2A | 6 | 100% | 3% | 4 | Search FMDV+2A | Search FMDV+2A |
3 | 2A | 4 | 40% | 6% | 8 | Search 2A | Search 2A |
4 | CO TRANSLATION | 2 | 67% | 2% | 2 | Search CO+TRANSLATION | Search CO+TRANSLATION |
5 | ECTO NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1 | 2 | 67% | 2% | 2 | Search ECTO+NUCLEOSIDE+TRIPHOSPHATE+DIPHOSPHOHYDROLASE+1 | Search ECTO+NUCLEOSIDE+TRIPHOSPHATE+DIPHOSPHOHYDROLASE+1 |
6 | MULTICISTRONIC | 1 | 50% | 2% | 2 | Search MULTICISTRONIC | Search MULTICISTRONIC |
7 | TRICISTRONIC | 1 | 50% | 2% | 2 | Search TRICISTRONIC | Search TRICISTRONIC |
8 | BICISTRONIC VECTOR | 1 | 19% | 4% | 5 | Search BICISTRONIC+VECTOR | Search BICISTRONIC+VECTOR |
9 | 2A SELF PROCESSING SEQUENCE | 1 | 50% | 1% | 1 | Search 2A+SELF+PROCESSING+SEQUENCE | Search 2A+SELF+PROCESSING+SEQUENCE |
10 | GENETIC DELIVERY | 1 | 50% | 1% | 1 | Search GENETIC+DELIVERY | Search GENETIC+DELIVERY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLEAVAGE ACTIVITIES | 9 | 48% | 10% | 13 |
2 | 2A LIKE SEQUENCES | 8 | 60% | 7% | 9 |
3 | 2A SEQUENCES | 6 | 100% | 3% | 4 |
4 | 2A PEPTIDE | 5 | 44% | 6% | 8 |
5 | MULTIPLE PROTEINS | 3 | 24% | 9% | 12 |
6 | 2A SEQUENCE | 3 | 60% | 2% | 3 |
7 | PREVENTS TUMOR GROWTH | 2 | 67% | 2% | 2 |
8 | THERAPEUTIC LEVELS | 2 | 16% | 8% | 10 |
9 | YERSINIA PESTIS CHALLENGE | 2 | 43% | 2% | 3 |
10 | DICISTRONIC TRANSCRIPTION UNITS | 1 | 100% | 2% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
E unum pluribus: multiple proteins from a self-processing polyprotein | 2006 | 109 | 52 | 46% |
T-cell receptor retrogenic mice: a rapid, flexible alternative to T-cell receptor transgenic mice | 2012 | 5 | 61 | 18% |
2A to the Fore - Research, Technology and Applications | 2010 | 9 | 185 | 19% |
Development of 2A peptide-based strategies in the design of multicistronic vectors | 2005 | 98 | 96 | 16% |
Challenges in monoclonal antibody-based therapies | 2009 | 32 | 55 | 9% |
Engineering human cells for in vivo secretion of antibody and non-antibody therapeutic proteins | 2011 | 1 | 73 | 15% |
In situ production of therapeutic monoclonal antibodies | 2015 | 0 | 99 | 13% |
Engineering humoral immunity as prophylaxis or therapy | 2015 | 0 | 55 | 7% |
Monoclonal antibodies as therapeutic agents in oncology and antibody gene therapy | 2007 | 25 | 51 | 4% |
Monoclonal antibody-based genetic immunotherapy | 2004 | 9 | 63 | 5% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PRECLIN ONCOL IMMUNOL | 1 | 33% | 1.5% | 2 |
2 | FRONTIER TUMOR IMMUNOL | 1 | 50% | 0.8% | 1 |
3 | GENET BREEDING REPROD GRASS FEEDING LIV | 1 | 50% | 0.8% | 1 |
4 | MASS SPE OMETRY PROTEOM CORE IL | 0 | 33% | 0.8% | 1 |
5 | N W EMBRYON STEM CELL | 0 | 33% | 0.8% | 1 |
6 | SOUTHWEST HOSPITAL | 0 | 33% | 0.8% | 1 |
7 | MED INNOVAT TRANSLAT | 0 | 25% | 0.8% | 1 |
8 | STEM CELL SAKYO KU | 0 | 14% | 0.8% | 1 |
9 | MICROBIAL CELL TORY | 0 | 13% | 0.8% | 1 |
10 | VINCE LOMBARDI GENE THER Y | 0 | 13% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000127959 | IRES//INTERNAL RIBOSOME ENTRY SITE IRES//INTERNAL RIBOSOME ENTRY SITE |
2 | 0.0000116853 | LENTIVIRAL VECTOR//LENTIVIRAL VECTORS//EXPT HEMATOL |
3 | 0.0000111999 | 3C PROTEASE//PICORNAVIRUS//PROTEINASE 3C |
4 | 0.0000109333 | SOMATIC CELL MUTANTS//CYTOKINE MOL MECH SECTNIH//NEOMYCIN PHOSPHOTRANSFERASE GENE |
5 | 0.0000101048 | TET SYSTEM//PTRIDENT//TET ON SYSTEM |
6 | 0.0000100152 | CHIMERIC ANTIGEN RECEPTOR//ADOPTIVE CELL THERAPY//CHIMERIC IMMUNE RECEPTOR |
7 | 0.0000097774 | TRIGGER FACTOR//NASCENT CHAIN//COTRANSLATIONAL FOLDING |
8 | 0.0000095011 | CYSTOCIN//SYNTH BIOMOLUMR 5246//THIODISACCHARIDE |
9 | 0.0000085650 | FERULOYLTYRAMINE//PORCELIA MACROCARPA//SEROTONIN DERIVATIVES |
10 | 0.0000072660 | CRE RECOMBINASE//LOXP//ROSA26 |